Overview
Hyo Song practices practicing medicine in Seoul, Republic of Korea.
Their clinical expertise encompasses Stargardt Macular Degeneration, Glioblastoma, and Astrocytoma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hyo S. Song
Is Hyo S. Song a top-rated expert for Stargardt Macular Degeneration?
MediFind is an objective health platform that identifies experts based on real-world data. Hyo S. Song is classified as an Experienced expert for Stargardt Macular Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hyo S. Song participate in research or clinical trials?
Yes. Hyo S. Song has published 8 articles and abstracts on conditions like Stargardt Macular Degeneration. You can view a list of Hyo S. Song's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaSong isExperienced. Learn about Astrocytoma.
- GlioblastomaSong isExperienced. Learn about Glioblastoma.
- Stargardt Macular Degeneration